Select Language

Free Registration

HLA-A*1101 & B2M & KRASG12A (VVVGAAGVGK)

HLA-A*1101 & B2M & KRASG12A (VVVGAAGVGK) Product List

Product Category
Protein (1)
Product Status
Launched (1)
Species
Human (1)
Tag
His Tag & Avi Tag (1)
Conjugate
Biotin-labeled (1)

Cat. No.	Species	Host	Product Description	Structure	Purity	Feature
HLA-H82E9	Human	HEK293	Biotinylated Human HLA-A*11:01&B2M&KRASG12A (VVVGAAGVGK) Complex Protein (Monomer, MALS verified)

Total: 1

HLA-A*1101 & B2M & KRASG12A (VVVGAAGVGK) Background

The Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) oncogene plays a critical role in the initiation and maintenance of pancreatic tumors and its signaling network represents a major target for therapeutic intervention. The Biotinylated Human HLA-A*1101 KRASG12A (VVVGAAGVGK) complex protein is a complex of HLA-A*1101 of the MHC Class I, B2M, and VVVGAAGVGK peptide of the KRASG12A.

Clinical Drug Information

English Name	Research Code	Highest Development Stage	Company	Indication	Clinical Trial
CB-2202	CB-2202	Phase 2 Clinical	Cennerv Pharma	Depressive Disorder, Major	Details

Marketed Drug Information

English Name	Research Code	Highest Development Stage	Company	First Brand Name	First Approved Country	First Indication	First Approved Company	First Approved Date	Indication	Clinical Trial
Toloxatone	MD-69276	Approved		Umoril, Humoryl, Perenum	France	Depression	null	1984-01-01	Depression	Details

Product List
Marketed Drug Information
Clinical Drug Information

Website Feedback

Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

order@acrobiosystems.com

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland